Portfolio company
Alessa Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops a drug-delivery platform for the localized release of therapies to treat patients with early-stage prostate cancer.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Alpfa Medical
The company develops pulsed field ablation systems to treat benign prostatic hyperplasia in men.
ESSA
This pharmaceutical company develops therapies for the treatment of prostate cancer for patients with advanced disease.
Alpha-9 Theranostics
This clinical-stage biotechnology company develops targeted radiopharmaceuticals to treat cancer patients by delivering radiation directly to tumours while sparing healthy tissue.
Allay Therapeutics
The company develops long-acting localized pain management technology for patients recovering from surgery.
NXThera
This company develops water vapour therapy systems to treat patients suffering from enlarged prostate and prostate cancer.
TRANSURETHRAL IMAGING & THERAPY
This company develops a transurethral ultrasound imaging and high-intensity focused ultrasound therapy system for urologists to treat prostate disease in outpatient procedures.
PNAS Therapeutics
This company develops a one-step drug delivery platform to create regenerative therapies and enhanced pharmaceutical formulations for biotechnology and healthcare partners.
Ravada Health
This company develops artificial intelligence and hardware to transform MRI scanners into non-invasive pathology platforms for biopsy-saving prostate cancer diagnostics.